Interpretation of WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment

doi:10.19982/j.issn.1000-6621.20230199

Abstract

Abstract:

World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment (2020 version guideline) on February 25, 2020, and guided the implementation of the 2020 version guideline through the implementation manual which contains the details of the implementation of guidance recommendations. The 2020 version guideline integrates the latest research since the WHO released Latent tuberculosis infection: updated and consolidated guidelines for programmatic management in 2018, and updates some recommendations. The author introduces the 2020 version guideline and interprets its key recommendations, hoping to provide a reference for the implementation of tuberculosis preventive treatment in China.

Key words: Mycobacterium tuberculosis, Infection, Protective agents, Consensus development conferences as topic

CLC Number:

R521
R825.2

Guo Tonglei, Xin Henan, Gao Lei. Interpretation of WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 723-727. doi: 10.19982/j.issn.1000-6621.20230199

Figures/Tables 1

References 7

[1]	Getahun H, Matteelli A, Chaisson RE, et al. Latent Mycobacterium tuberculosis infection. N Engl J Med, 2015, 372(22): 2127-2135. doi:10.1056/NEJMra1405427. doi: 10.1056/NEJMra1405427 URL
[2]	Cohen A, Mathiasen VD, Schön T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2019, 54(3):1900655. doi:10.1183/13993003.00655-2019. doi: 10.1183/13993003.00655-2019 URL
[3]	Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ, 2018, 362: k2738. doi:10.1136/bmj.k2738. doi: 10.1136/bmj.k2738
[4]	World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018.
[5]	World Health Organization. WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment. Geneva: World Health Organization, 2020.
[6]	World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva: World Health Organization, 2015.
[7]	World Health Organization. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis-Tests for tuberculosis infection. Geneva: World Health Organization, 2022.

[1]	Qin Huifang, Liang Xiaoyan, Zhou Lingyun, Lan Yumei, Lin Mei, Zhang Zhitong, Huang Yan, Wei Xiaolin, Liang Dabin. Analysis on the effect of GeneXpert MTB/RIF single test and mixed test on sputum samples for actively screening tuberculosis in key population of Guangxi [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 880-884.
[2]	Du Yu, Zhang Haipeng, Wang Peng. Research status and application progress of mycobacteria phages [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 897-903.
[3]	Bi Xiuli, Geng Hong, Jin Jin. The role of myeloid system and CD4⁺T cells in Mycobacterium tuberculosis infection and immunopathology [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 904-912.
[4]	Huang Wenbin, Chen Liping, Zhang Wang, Xiao Ting, Zhang Mane, Wu Dingchang. Establishment of a cross primer isothermal amplification technique for rapid detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2023, 45(8): 734-743.
[5]	Zhao Yong, Liang Lili, Jiang Nan. Impact of targeted regulation of miR-144-3p by LncRNA GAS5 on macrophage apoptosis and inflammatory response in Mycobacterium tuberculosis infected macrophages [J]. Chinese Journal of Antituberculosis, 2023, 45(8): 744-751.
[6]	Wang Min, Yuan Yuan, Tan Shouyong, Yang Zilong, Feng Zhiyu, Zhang Hong, Wu Di, Chen Zeying, Huang Xianlin, Kuang Haobin. Analysis of risk factors for extensive lung focus and cavities in type 2 diabetes mellitus patients complicated with newly treated pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(8): 761-767.
[7]	Song Yuanyuan, Xia Hui, Zhao Yanlin. Development process of setting of critical concentrations for phenotypic drug susceptibility testing of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 631-638.
[8]	Xin Henan, Gao Lei. Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 639-643.
[9]	Zhao Guolian, Lei Qian, Wang Pei, Ren Yunxia, Guan Jing. Value of DNA real-time fluorescence isothermal amplification method and combined testing in early diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 681-686.
[10]	Zhuo Wenji, Zhang Chenchen, Chen Xunxun, Wei Wenjing, Yu Meiling, Peng Kehao, Xu Liuyue, Chen Yanmei. Analysis of drug resistance characteristics of pulmonary tuberculosis in children in Guangdong, 2014—2020 [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 687-692.
[11]	Liu Dingyi, Sun Hong, Sheng Gang, Sun Zhaogang. Recent advances in the source and biological function of bacterial DNA in extracellular vesicles [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 693-698.
[12]	Senior Department of Tuberculosis, the th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Tuberculosis Control Branch of China Intrnational Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of superficial lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 531-542.
[13]	Senior Department of Tuberculosis, the th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Tuberculosis Control Branch of China Intrnational Exchange and Promotive Association for Medical and Health Care. Expert consensus on the clinical application of nucleic acid MALDI-TOF MS technique in the diagnosis of tuberculosis and non-tuberculosis mycobacteriosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 543-558.
[14]	He Ping, Wang Yiting, Song Zexuan, Xia Hui, Wang Shengfen, He Wencong, Zheng Yang, Zhao Yanlin. Preliminary study on the gene function of Mycobacterium tuberculosis Rv2333c in macrophages [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 566-574.
[15]	Wang Nenhan, Tian Lili, Chen Shuangshuang, Zhao Yanfeng, Fan Ruifang, Chen Hao, Ren Yixuan, Zhang Jie, Yi Junli, Yang Xinyu, Yu Lan, Ding Beichuan, Li Chuanyou, Dai Xiaowei. Study on the detection of rifampicin resistance of Mycobacterium tuberculosis in sputum samples using fluorescence PCR probe melting curve technique [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 583-588.